200 related articles for article (PubMed ID: 33562701)
1. Study of Neuroprotection by a Combination of the Biological Antioxidant (
Trabolsi C; Takash Chamoun W; Hijazi A; Nicoletti C; Maresca M; Nasser M
Molecules; 2021 Feb; 26(4):. PubMed ID: 33562701
[TBL] [Abstract][Full Text] [Related]
2. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of postischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia.
Fu H; Hosomi N; Pelisch N; Nakano D; Liu G; Ueno M; Miki T; Masugata H; Sueda Y; Itano T; Matsumoto M; Nishiyama A; Kohno M
J Hypertens; 2011 Nov; 29(11):2210-9. PubMed ID: 21934531
[TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke.
Saad MA; Abbas AM; Boshra V; Elkhateeb M; El Aal IA
Acta Physiol Hung; 2010 Jun; 97(2):159-71. PubMed ID: 20511125
[TBL] [Abstract][Full Text] [Related]
5. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
[TBL] [Abstract][Full Text] [Related]
6. Candesartan, angiotensin II type 1 receptor blocker is able to relieve age-related cognitive impairment.
Trofimiuk E; Wielgat P; Braszko JJ
Pharmacol Rep; 2018 Feb; 70(1):87-92. PubMed ID: 29331792
[TBL] [Abstract][Full Text] [Related]
7. Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats.
Krikov M; Thone-Reineke C; Müller S; Villringer A; Unger T
J Hypertens; 2008 Mar; 26(3):544-52. PubMed ID: 18300867
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P
Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009
[TBL] [Abstract][Full Text] [Related]
9. Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection.
Fagan SC; Kozak A; Hill WD; Pollock DM; Xu L; Johnson MH; Ergul A; Hess DC
J Hypertens; 2006 Mar; 24(3):535-9. PubMed ID: 16467657
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of candesartan against cerebral ischemia in spontaneously hypertensive rats.
Lu Q; Zhu YZ; Wong PT
Neuroreport; 2005 Nov; 16(17):1963-7. PubMed ID: 16272888
[TBL] [Abstract][Full Text] [Related]
11. Candesartan protects against d-galactose induced - Neurotoxicity and memory deficit via modulation of autophagy and oxidative stress.
Khedr NF; Werida RH; Abo-Saif MA
Toxicol Appl Pharmacol; 2022 Jan; 435():115827. PubMed ID: 34906534
[TBL] [Abstract][Full Text] [Related]
12. Candesartan reduces superoxide production after global cerebral ischemia.
Sugawara T; Kinouchi H; Oda M; Shoji H; Omae T; Mizoi K
Neuroreport; 2005 Mar; 16(4):325-8. PubMed ID: 15729131
[TBL] [Abstract][Full Text] [Related]
13. Candesartan cilexetil--a review of effects on cardiovascular complications in hypertension and chronic heart failure.
Meredith PA
Curr Med Res Opin; 2007 Jul; 23(7):1693-705. PubMed ID: 17588300
[TBL] [Abstract][Full Text] [Related]
14. Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade.
Barakat W; Safwet N; El-Maraghy NN; Zakaria MN
Eur J Pharmacol; 2014 Feb; 724():43-50. PubMed ID: 24378346
[TBL] [Abstract][Full Text] [Related]
15. Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress.
Hamai M; Iwai M; Ide A; Tomochika H; Tomono Y; Mogi M; Horiuchi M
Neuropharmacology; 2006 Sep; 51(4):822-8. PubMed ID: 16824557
[TBL] [Abstract][Full Text] [Related]
16. Learning and memory improvement and neuroprotection of Gardenia jasminoides (Fructus gardenia) extract on ischemic brain injury rats.
Zhang H; Lai Q; Li Y; Liu Y; Yang M
J Ethnopharmacol; 2017 Jan; 196():225-235. PubMed ID: 27940085
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment with bisoprolol and vitamin E alone or in combination provides neuroprotection against cerebral ischemia/reperfusion injury in rats.
Salehi C; Seiiedy M; Soraya H; Fazli F; Ghasemnejad-Berenji M
Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):685-695. PubMed ID: 33106920
[TBL] [Abstract][Full Text] [Related]
18. [Candesartan - a novel AT(1)-angiotensin receptor blocker: peculiarities of pharmacology and experience of use in arterial hypertension].
Sidorenko BA; Preobrazhenskiĭ DV; Soplevenko AV; Ivanova NA; Stetsenko TM
Kardiologiia; 2004; 44(1):55-65. PubMed ID: 15029149
[TBL] [Abstract][Full Text] [Related]
19. Silencing VEGF-B Diminishes the Neuroprotective Effect of Candesartan Treatment After Experimental Focal Cerebral Ischemia.
Ishrat T; Soliman S; Eldahshan W; Pillai B; Ergul A; Fagan SC
Neurochem Res; 2018 Oct; 43(10):1869-1878. PubMed ID: 30088238
[TBL] [Abstract][Full Text] [Related]
20. Effect of combined treatment with curcumin and candesartan on ischemic brain damage in mice.
Awad AS
J Stroke Cerebrovasc Dis; 2011 Nov; 20(6):541-8. PubMed ID: 20719539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
